31 related articles for article (PubMed ID: 24685678)
1. Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer.
Nicoud MB; Ospital IA; Táquez Delgado MA; Riedel J; Fuentes P; Bernabeu E; Rubinstein MR; Lauretta P; Martínez Vivot R; Aguilar MLÁ; Salgueiro MJ; Speisky D; Moretton MA; Chiappetta DA; Medina VA
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834958
[TBL] [Abstract][Full Text] [Related]
2. Mast Cells May Differentially Regulate Growth of Lymphoid Neoplasms by Opposite Modulation of Histamine Receptors.
Paudel S; Mehtani D; Puri N
Front Oncol; 2019; 9():1280. PubMed ID: 31824856
[TBL] [Abstract][Full Text] [Related]
3. Histamine receptors and cancer pharmacology: an update.
Massari NA; Nicoud MB; Medina VA
Br J Pharmacol; 2020 Feb; 177(3):516-538. PubMed ID: 30414378
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.
Vila-Leahey A; Oldford SA; Marignani PA; Wang J; Haidl ID; Marshall JS
Oncoimmunology; 2016 Jul; 5(7):e1151591. PubMed ID: 27622015
[TBL] [Abstract][Full Text] [Related]
5. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
6. Lack of Association between rs2067474 Polymorphism in Histamine Receptor H2 Gene and Breast Cancer in Chinese Han Population.
Cai WK; Zhang JB; Wang NM; Wang YL; Zhao CH; Lu J; He GH
ScientificWorldJournal; 2015; 2015():545292. PubMed ID: 25922853
[TBL] [Abstract][Full Text] [Related]
7. TGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development.
Tirado-Rodriguez B; Ortega E; Segura-Medina P; Huerta-Yepez S
J Immunol Res; 2014; 2014():318481. PubMed ID: 25110717
[TBL] [Abstract][Full Text] [Related]
8. Growth Hormone and the Epithelial-to-Mesenchymal Transition.
Brittain AL; Basu R; Qian Y; Kopchick JJ
J Clin Endocrinol Metab; 2017 Oct; 102(10):3662-3673. PubMed ID: 28938477
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell-like properties in fibroblasts.
Chang Y; Li H; Guo Z
Cell Physiol Biochem; 2014; 34(3):703-14. PubMed ID: 25171291
[TBL] [Abstract][Full Text] [Related]
10. Fibroblasts induce epithelial to mesenchymal transition in breast tumor cells which is prevented by fibroblasts treatment with histamine in high concentration.
Porretti JC; Mohamad NA; Martín GA; Cricco GP
Int J Biochem Cell Biol; 2014 Jun; 51():29-38. PubMed ID: 24685678
[TBL] [Abstract][Full Text] [Related]
11. Histamine prevents radiation-induced mesenchymal changes in breast cancer cells.
Galarza TE; Mohamad NA; Táquez Delgado MA; Vedoya GM; Crescenti EJ; Bergoc RM; Martín GA; Cricco GP
Pharmacol Res; 2016 Sep; 111():731-739. PubMed ID: 27473821
[TBL] [Abstract][Full Text] [Related]
12. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells.
Galarza TE; Táquez Delgado MA; Mohamad NA; Martín GA; Cricco GP
Biochem Pharmacol; 2020 Oct; 180():114177. PubMed ID: 32721509
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells.
Lee Y; Jung WH; Koo JS
Breast Cancer Res Treat; 2015 Sep; 153(2):323-35. PubMed ID: 26285644
[TBL] [Abstract][Full Text] [Related]
14. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
15. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
